Phase I Study of ABT-888 in Combination With Gemcitabine in Patients With Advanced Malignancies
Phase of Trial: Phase I
Latest Information Update: 01 Sep 2017
At a glance
- Drugs Gemcitabine (Primary) ; Veliparib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 01 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 31 Jul 2013 Planned end date changed from 1 Mar 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 31 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.